Premenstrual syndrome


Misleading and Corrective Advertising

Bayer has become somewhat of a federal poster child for the FDA’s request for the placement of corrective advertising, which is designed to correct misleading messages. In 2009, for example, as the Federal Register reads, Bayer HealthCare Pharmaceuticals produced and aired corrective DTC advertising for Yaz, a birth control pill, following a warning from FDA […]

Continue Reading